BRCA2 and neoplasm: Mitochondrial dysfunction and loss of BRCA2 in sporadic cancer lead to nuclear genomic instability, cumulative mutations, and tumor progression but also enhance cancer cells sensitivity to apoptosis induced by PARP inhibitors [95].